Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study

Lancet Neurology

Volumn 6, Issue 5, 2007, Pages 407-413

  Wong, Ka Sing ^a   Chen, Christopher ^b   Ng, Ping Wing ^c   Tsoi, Tak Hong ^d   Li, Ho Lun ^e   Fong, Wing Chi ^f   Yeung, Jonas ^g   Wong, Chi Keung ^h   Yip, Kin Keung ⁱ   Gao, Hong ^j   Wong, Hwee Bee ^j  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c UNITED CHRISTIAN HOSPITAL   (Hong Kong)

^d PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

^e PRINCESS MARGARET HOSPITAL   (Hong Kong)

^f QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^g Alice Ho Nethersole Hospital   (Hong Kong)

^h NORTH DISTRICT HOSPITAL   (Hong Kong)

ⁱ RUTTONJEE HOSPITAL   (Hong Kong)

^j Clinical Trials and Epidemiology Research Unit   (Singapore)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

ADULT; AGED; ARTICLE; BLEEDING; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DOPPLER ECHOGRAPHY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROIMAGING; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ARTERIAL OCCLUSIVE DISEASES; ASIAN CONTINENTAL ANCESTRY GROUP; ASPIRIN; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; FEMALE; HEMORRHAGE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; NADROPARIN; TREATMENT OUTCOME;

EID: 34047246661     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(07)70079-0     Document Type: Article

References (28)

1. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke. Lancet 349 (1997) 1641-1649
2. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke. Lancet 349 (1997) 1569-1581
3. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 (1995) 1581-1587
4. Bath P. Low molecular weight heparin in acute stroke. Expert Opin Investig Drugs 7 (1998) 1323-1330
5. Hacke W., Kaste M., Fieschi C., et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 352 (1998) 1245-1251
6. Zivin J. Thrombolytic stroke therapy: past, present, and future. Neurology 53 (1999) 14-19
7. del Zoppo G. Antithrombotic treatments in acute ischemic stroke. Thromb Haemost 82 (1999) 938-946
8. Samama M., Desnoyers P., Conard J., and Bousser M. Acute ischemic stroke and heparin treatments. Thromb Haemost 78 (1997) 173-179
9. Kay R., Wong K., Yu Y., et al. Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med 333 (1995) 1588-1593
10. Hommel M., and FISS-bis Investigators Group. Fraxiparine in Ischemic Stroke Study (FISS bis). Cerebrovasc Dis 8 suppl 4 (1998) 19
11. Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. JAMA 279 (1998) 1265-1272
12. Bath P., Lindenstrom E., Boysen G., et al. Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial. Lancet 358 (2001) 702-710
13. Gubitz G., Sandercock P., and Counsell C. Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev 3 (2004) CD000024.
14. Bath P., Iddenden R., and Bath F. Low-molecular-weight heparins and heparinoids in acute ischemic stroke: a meta-analysis of randomized controlled trials. Stroke 31 (2000) 1770-1778
15. Li H., and Wong K. Racial distribution of intracranial and extracranial atherosclerosis. J Clin Neurosci 10 (2003) 30-34
16. Sacco R., Kargman D., Gu Q., and Zamanillo M. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 26 (1995) 14-20
17. Caplan L., Gorelick P., and Hier D. Race, sex and occlusive cerebrovascular disease: a review. Stroke 17 (1986) 648-655
18. Wong K., Li H., Chan Y., et al. Use of transcranial Doppler ultrasound to predict outcome in patients with intracranial large-artery occlusive disease. Stroke 31 (2000) 2641-2647
19. Wong K., Huang Y., Gao S., Lam W., Chan Y., and Kay R. Intracranial stenosis in Chinese patients with acute stroke. Neurology 50 (1998) 812-813
20. Adams H., Bendixen B., Leira E., et al. Antithrombotic treatment of ischemic stroke among patients with occlusion or severe stenosis of the internal carotid artery: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 53 (1999) 122-125
21. Wong K., Lam W., Liang E., Huang Y., Chan Y., and Kay R. Variability of magnetic resonance angiography and computed tomography angiography in grading middle cerebral artery stenosis. Stroke 27 (1996) 1084-1087
22. Moher D., Schulz K., and Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 285 (2001) 1987-1991
23. Caplan L. Resolved: heparin may be useful in selected patients with brain ischemia. Stroke 34 (2003) 230-231
24. Wong K., Gao S., Chan Y., et al. Mechanisms of acute cerebral infarctions in patients with middle cerebral artery stenosis: a diffusion-weighted imaging and microemboli monitoring study. Ann Neurol 52 (2002) 74-81
25. Lees K., Asplund K., Carolei A., et al. Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. Lancet 355 (2000) 1949-1954
26. Fisher M., Albers G., Donnan G., et al. Enhancing the development and approval of acute stroke therapies: stroke therapy academic industry roundtable. Stroke 36 (2005) 1808-1813
27. Duncan P., Samsa G., Weinberger M., et al. Health status of individuals with mild stroke. Stroke 28 (1997) 740-745
28. Lees K., Hankey G., and Hacke W. Design of future acute-stroke treatment trials. Lancet Neurol 2 (2003) 54-61